Cannabis Law Report

APRIL 14, 2022

Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country. by eating or smoking cannabis) are unknown. Since growing cannabis has not always been legal, growers did not always choose pesticides that were “approvable” by EPA.

Environment 52

Environment Agriculture Compliance Compliance 52

Canna Law Blog

DECEMBER 21, 2023

Welcome to the eighth annual “State of the State” post on Oregon cannabis. Sales fell (again) along with licensee numbers (for the first time) According to OLCC data , retail sales between January 1, 2023 and November 30, 2023 clocked in at $874 million. This year’s harvest came in at an unwelcome 15% higher than 2022.

Hemp 86

Hemp Retail Compliance Compliance 86

Cannabis Law Report

JANUARY 3, 2022

PRAGUE, CZECH REPUBLIC – A new Czech law relaxes rules surrounding the prescription of medical cannabis and the regulations on technical marijuana. A higher dose of THC (three times the current threshold) will also be allowed in technical cannabis and its derived products. Source: CTK.

Media 52

Media Chronic Pain Patients Treatment 52

Veriheal

FEBRUARY 9, 2023

Although many rely on imaging scans to diagnose illnesses and get treatment of various kinds, getting into the enclosed chamber can be stressful. All imaging and behavioral data will be accessible to the public after the study is complete. Do not attempt to self-diagnose or prescribe treatment based on the information provided.

Clinical Trials 91

Clinical Trials Research and Development Data Collective 91

Cannabis Law Report

SEPTEMBER 7, 2022

The UK’s fastest growing medical cannabis clinic has opened a waiting list as demand soars post-COVID. Cantourage Clinic is a leading medical cannabis clinic in the UK with a difference. . According to patient data, over 50 per cent of patients at Cantourage Clinic mention anxiety as their primary or secondary indication.

Patients 52

Patients Conditions Treatment Education 52

Cannabis Law Report

MARCH 11, 2022

10 March 2022. The Technical Note “Management of Cannabis Waste in the context of activities that produce cannabis for medicinal purposes” was published on 8 February 2022. As a result, cannabis waste produced from different economic activities will be subject to different rules.

Medicine 52

Medicine Treatment Packaging Digestion 52

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Additionally, participants also reported feeling increased self-awareness and general improvement in relationships following their treatment.

Clinical Trials 92

Clinical Trials Research and Development Therapy Policy 92

Cannabis Law Report

APRIL 21, 2022

and Canada highlights mounting cases of cannabis poisoning among pets and sheds new light on symptoms, treatments, and outcomes. Richard Quansah Amissah of the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and colleagues present these findings in the open-access journal PLOS ONE on April 20, 2022.

Pets 52

Pets Research and Development Topical Consumption 52

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. The deadline for proposals is Friday, July 16. The deadline for proposals is Friday, July 16. Between Dec.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. 11 May 2022. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Veriheal

JUNE 19, 2023

The psychedelic drugs here include LSD, MDMA, psilocybin, ketamine, and ayahuasca, which are in high demand for mental health treatment and other therapeutic reasons. As of 2022, the global psychedelics market was valued at $4.87 billion in the next six years. .” Why Is the Psychedelics Market Growing?

Therapy 105

Therapy Treatment Patients Policy 105

Veriheal

DECEMBER 23, 2022

Cannabis prohibition is doing more than just creating a barricade between consumers and safe products. State Cannabis Contaminant Rules Vary Widely,” consumers have little choice but to purchase contaminated cannabis products. Researchers Inspected Cannabis Products for Contaminants. Led by Dr. Maxwell C.K.

Research and Development 77

Research and Development Agriculture Data Extraction 77

Cannabis Law Report

JULY 25, 2022

Mindbio Therapeutics , a subsidiary of cannabis and psychedelics holding company Blackhawk Growth Corp. The data from this study is currently being assembled and MindBio is set to further announce the new findings. Press Release. together with research collaborators at the University of Auckland , have received NZ$1.44

Microdosing 52

Microdosing Clinical Trials Research and Development Data 52

Veriheal

MARCH 8, 2022

Montana’s adult-use cannabis industry is on track to yield $130 million — a sales prediction made by the Governor’s budget office — in its initial year of operation. Adults age 21 and over have been legally allowed to purchase a maximum of one ounce of recreational cannabis in Montana since January 1, 2022. million and $2.9

Programs 97

Programs Recreational Edibles Tincture 97

Veriheal

AUGUST 23, 2023

Over the span of a month, the participants were closely monitored, providing a total of 192 observations to form a robust data set. In June 2022, a study offered compelling evidence that taking microdoses of psilocybin mushrooms had a beneficial impact on mood.

Microdosing 88

Microdosing Data Treatment Conditions 88

Veriheal

AUGUST 31, 2022

Nonetheless, the data speaks differently. . The research letter written by Dr. Harocopos and his team looked into the first two months of OPC operation by collecting data from program staff on individuals using the services at the two OPC sites. 31, 2022, 78% identified as male, 36.9% The Research Letter. 30, 2021, and Jan.

Consumption 99

Consumption Data Treatment Collective 99

The Cannigma

OCTOBER 17, 2022

Cannabis is one of the most commonly used substances during pregnancy. Stigmas around weed are subsiding and the plant is becoming more prominent, leading to a rise in cannabis use. of women use cannabis during pregnancy , although research suggests the number could be as high as 12.1% Pregnant women are no exception.

Research and Development 88

Research and Development Data THC Cannabis 88

Cannabis Law Report

AUGUST 24, 2022

Here’s what they say – nothing that any cannabis user hasn’t know since the 19080’s ! 25 August 2022. Results from the third Cannabis as Medicine study. The survey found 37 percent of respondents had received a legal prescription for medicinal cannabis – a significant increase from the 2.5

Medicine 52

Medicine Legalization Chronic Pain Access 52

Veriheal

AUGUST 9, 2023

In the midst of ongoing debates about cannabis legalization, a new survey by the American Psychiatric Association (APA) and Morning Consult offers intriguing insights. It compares public perceptions of cannabis’ dangers and addictiveness with those of cigarettes, alcohol, opioids, and vapes.

Education 88

Education Vaping Cannabis Consumption 88

Cannabis Law Report

DECEMBER 26, 2021

The patent relates to improved technology for detection and maintenance of the optimal therapeutic psychedelic state, which Entheon intends to study through the monitoring of electroencephalogram (EEG) biomarkers in order to optimize the treatment of neuropsychiatric conditions. US Provisional Patent Filed. About Entheon Biomedical Corp.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

APRIL 13, 2022

The Center Square) – Marijuana sales in Colorado continued a downward trend in February totaling $145 million, according to the state’s latest market data. New Report Format in 2022! The monthly reports are now replaced with two reports that have data from every month since 2014. Marijuana Sales Report, 2014 to Date.

Marijuana 52

Marijuana Data Retail Collective 52

Cannabis Law Report

JUNE 19, 2022

Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. June 14, 2022 02:00 AM Eastern Daylight Time. Dr. Nick Allen, co-founder and CEO of Ksana Health, commented: “Psychedelic treatments are offering exciting new approaches to recovery from mental disorders.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Veriheal

JULY 29, 2022

A new report from the United Nations Office on Drugs and Crime (UNODC) suggests that cannabis consumption levels soared amid COVID-19 lockdowns and wide-ranging legalization. ” Cannabis has long been acknowledged as the most widely used illicit drug in the world. and Guam have legalized cannabis for recreational purposes.

Legalization 84

Legalization Consumption Cannabis Cannabinoids 84

Veriheal

MAY 17, 2023

According to the 2022 Legislative Finance Committee Corrections Department Performance Report Card, about 35% of detentions in the state’s corrections department were for technical parole offenses. .” Ideally, people grappling with the effect of substance use disorder should be given treatment and assistance, not jailed.

Treatment 87

Treatment Policy Legislation Collective 87

Cannabis Law Report

AUGUST 18, 2022

Smith , a partner with the firm and co-leader of the firm’s Life Sciences & Health Effects Team, will lead the practice, bringing together scientist-attorneys and experienced litigators to support clients that are driving innovation in mental health treatments. BUFFALO, N.Y. , Aug. Tweet this. However, change appears imminent.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

JULY 24, 2022

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 billion by 2029.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Brian Schatz & Cory Booker to Acting Director Tabak and Commissioner Califf (May 11, 2022), [link]. [2] Defining Psychedelics.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

DECEMBER 20, 2021

So… what does “UAE eases drug laws: No more jail for those bringing in cannabis ingredient” actually mean? The UAE has eased some of its strict drug laws and lessened penalties for travellers, who arrive in the country with products containing Tetrahydrocannabinol (THC), the main active chemical in cannabis (hashish).

Law 52

Law Data Treatment Patients 52

Cannabis Law Report

JANUARY 21, 2022

Supreme Court to hear her appeal over coverage of medical marijuana treatments, as reported in the article “ U.S. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Copyright © 2022 by A.M. For more information, visit www.ambest.com. Best Company, Inc.

Treatment 52

Treatment Data Business Access 52

Cannabis Law Report

OCTOBER 22, 2021

Food and Drug Administration (“FDA”) standards have been initiated in preparation for human clinical studies, expected in early 2022; and. Cybin continues to demonstrate superior properties of its CYB003 and CYB004 programs as we progress toward first-in-human studies, expected in early 2022.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

AUGUST 27, 2021

On August 19, 2021, the New Jersey Cannabis Regulatory Commission (CRC) approved the Specially Adopted Personal Use Cannabis Rules (the “Rules”). The Rules will be effective until at least August 19, 2022. People with prior criminal convictions can qualify for a cannabis business license. License Application Type.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Cannabis Law Report

AUGUST 12, 2022

In both his testimony and written comments , Jonathan praised policymakers’ mission to regulate intoxicating compounds as adult-use cannabis, but raised objections to the treatment of hemp products—with any amount of THC—with burdensome restrictions, such as age limits. Here’s some local coverage of the hearing.

Hemp 52

Hemp THC Food Legislation 52

Veriheal

DECEMBER 27, 2022

The subjective nature of self-reported data can plague research. In an August 2022 study published by the Journal of the American Medical Association (JAMA) , psilocybin appears to be an effective tool for reducing problematic alcohol consumption. Methamphetamine. Amphetamine. Opiates (heroin, codeine).

Research and Development 79

Research and Development Therapy Consumption DEA 79

Cannabis Law Report

JANUARY 4, 2022

Expands Agrify’s Footprint to Lucrative and Fast-Growing Florida Cannabis Market. Medical marijuana treatment centers like Gold Leaf are the only businesses currently authorized to cultivate, process, and dispense low-THC cannabis and medical marijuana in Florida. BILLERICA, Mass., BILLERICA, Mass., About Agrify TTK Solution.

Extraction 52

Extraction Cultivation Programs Data 52

Cannabis Law Report

JUNE 8, 2022

Published: Jun 07, 2022. MDMA-assisted therapy, a novel treatment for PTSD with FDA breakthrough therapy designation, is on track for NDA submission in 2023 pending results of the confirmatory Phase 3 trial. to serve on its Board of Directors, effective June 2, 2022. He holds a Ph.D. from Princeton University and a B.A.

Therapy 52

Therapy Treatment Access Patients 52

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98